Risk Minimisation: Tools and Evaluation of Effectiveness.

At the World Drug Safety Congress Europe 2014 event, Michael Forstner, Head PV Europe, Boehringer Ingelheim, gave the presentation “Risk Minimisation: Tools and Evaluation of Effectiveness.”

Download and learn:

  • What is happening?
  • What does this mean?
  • Nature of errors made in case and literature review which may be due to lack of vigilance
  • Can’t we just hire more people and divide up the work?
  • Vigilance decrement
  • Person approach vs. system approach to human error
  • What are the implications for pharmacovigilance?
  • Candidates for optimization of the data quantity/quality tradeoff:
  • Should we try a structured methodology for error analysis?
  • Conclusions

Download Presentation

Found this interesting? You might also be interested in attending our World Drug Safety Congress Europe 2015 event, held this 8-9th September 2015 in Berlin.  Find out more

Leave a Reply

Your email address will not be published. Required fields are marked *